Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $823.05 billion, total revenue of $166.46 billion and a weighted average PE ratio of 53.28.
Market Cap
823.05B
Revenue
166.46B
Profits
15.45B
PE Ratio
53.28
Profit Margin
9.28%
Dividend Yield
0.19%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 232.46B | -0.95% | 2,880,899 | 43.74B |
| 2 | DHR | Danaher Corporation | 166.69B | -1.63% | 3,904,102 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 57.12B | 0.46% | 525,518 | 4.17B |
| 4 | IQV | IQVIA Holdings Inc. | 40.48B | -1.49% | 1,350,611 | 15.90B |
| 5 | A | Agilent Technologies, Inc. | 39.59B | -3.58% | 2,603,391 | 6.95B |
| 6 | NTRA | Natera, Inc. | 31.99B | -3.78% | 1,453,912 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 29.84B | -2.40% | 188,884 | 3.94B |
| 8 | WAT | Waters Corporation | 23.06B | -1.83% | 550,744 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 22.46B | 0.74% | 1,060,567 | 13.77B |
| 10 | ILMN | Illumina, Inc. | 21.64B | -2.51% | 1,901,661 | 4.29B |
| 11 | DGX | Quest Diagnostics Incorporated | 21.08B | -0.40% | 1,132,562 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.44B | 0.09% | 1,613,370 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.21B | -1.16% | 230,292 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 14.45B | 0.14% | 2,119,788 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 13.94B | 0.03% | 1,397,309 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 12.75B | -2.39% | 1,603,640 | 2.81B |
| 17 | CRL | Charles River Laboratories International, Inc. | 10.81B | -1.69% | 866,972 | 4.02B |
| 18 | QGEN | Qiagen N.V. | 9.80B | -1.67% | 1,957,977 | 2.07B |
| 19 | RDNT | RadNet, Inc. | 5.49B | -2.82% | 625,932 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.45B | -0.88% | 1,790,980 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.06B | -6.32% | 622,337 | 254.14M |
| 22 | GRAL | GRAIL, Inc. | 3.77B | -0.76% | 727,777 | 141.83M |
| 23 | VCYT | Veracyte, Inc. | 3.29B | 1.39% | 749,669 | 495.14M |
| 24 | WGS | GeneDx Holdings Corp. | 3.12B | -1.10% | 703,792 | 402.19M |
| 25 | TWST | Twist Bioscience Corporation | 2.54B | 0.34% | 1,352,769 | 376.57M |
| 26 | NEOG | Neogen Corporation | 2.01B | -2.22% | 2,039,316 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.65B | -0.31% | 5,904,410 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.17B | -1.82% | 289,253 | 343.53M |
| 29 | CDNA | CareDx, Inc. | 1.03B | -2.72% | 630,447 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 982.66M | - | 2,373,168 | 642.07M |
| 31 | PSNL | Personalis, Inc. | 878.28M | 2.91% | 3,108,012 | 69.10M |
| 32 | FLGT | Fulgent Genetics, Inc. | 868.02M | -1.99% | 310,493 | 315.55M |
| 33 | MYGN | Myriad Genetics, Inc. | 551.83M | -1.99% | 1,050,184 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 344.64M | -3.93% | 26,543 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 264.46M | 5.68% | 216,536 | 77.08M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 190.19M | 0.23% | 50,865 | 4.40M |
| 37 | MDXH | MDxHealth SA | 190.07M | 3.50% | 173,943 | 103.07M |
| 38 | FONR | FONAR Corporation | 122.08M | -0.03% | 74,449 | 105.43M |
| 39 | XGN | Exagen Inc. | 106.29M | -2.90% | 563,560 | 63.60M |
| 40 | BDSX | Biodesix, Inc. | 62.69M | -5.40% | 408,466 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 41.17M | -2.08% | 15,817 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 19.53M | 0.12% | 255,186 | 513.02M |
| 43 | MYNZ | Mainz Biomed N.V. | 10.51M | -2.52% | 360,809 | 659.94K |
| 44 | MBAI | Check-Cap Ltd. | 10.06M | -1.71% | 7,268 | - |
| 45 | ADVB | Advanced Biomed Inc. | 6.41M | -6.54% | 19,224 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 6.15M | -3.52% | 70,517 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 5.58M | 6.94% | 11,856 | - |
| 48 | ISPC | iSpecimen Inc. | 3.83M | -9.24% | 1,666,057 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 2.27M | -6.64% | 56,890 | 29.52M |